1-20 of 103
M. Dowsett
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract TC-02: When to do a window trial

Free
M. Dowsett, S. Hurvitz
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): TC-02.
https://doi.org/10.1158/1538-7445.SABCS23-TC-02
Published: 02 May 2024
View articletitled, Abstract TC-02: When to do a window trial
Journal Articles

Abstract PL1: Genomic Profiling in Early Stage ER Positive Breast Cancers/Precision Medicine

Free
M Dowsett
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PL1.
https://doi.org/10.1158/1538-7445.SABCS21-PL1
Published: 15 February 2022
View articletitled, Abstract PL1: Genomic Profiling in Early Stage ER Positive Breast Cancers/Precision Medicine
Journal Articles

Abstract P2-05-02: Age-related genetic and epigenetic changes in estrogen-receptor positive breast cancer

Free
EF Schuster, M Dowsett
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): P2-05-02.
https://doi.org/10.1158/1538-7445.SABCS18-P2-05-02
Published: 15 February 2019
View articletitled, Abstract P2-05-02: Age-related genetic and epigenetic changes in estrogen-receptor positive breast cancer
Journal Articles

Abstract ES5-2: Clinical and molecular profiles to identify who is at risk?

Free
M Dowsett
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): ES5-2.
https://doi.org/10.1158/1538-7445.SABCS18-ES5-2
Published: 15 February 2019
View articletitled, Abstract ES5-2: Clinical and molecular profiles to identify who is at risk?
Journal Articles

Abstract P4-01-01: Molecular residual disease detection with circulating tumor DNA analysis predicts relapse in patients with early stage breast cancer

Free
N Turner, I Garcia-Murillas, N Chopra, I Comino-Mendez, M Beaney, H Tovey, R Cutts, C Swift, D Kriplani, M Afentakis, S Hrebien, G Walsh, S Johnston, A Ring, S Russell, A Evans, A Skene, D Wheatley, M Dowsett, I Smith
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): P4-01-01.
https://doi.org/10.1158/1538-7445.SABCS18-P4-01-01
Published: 15 February 2019
View articletitled, Abstract P4-01-01: Molecular residual disease detection with circulating tumor DNA analysis predicts relapse in patients with early stage breast cancer
Journal Articles

Abstract P4-02-01: Analytical validation of an automated digital scoring protocol for Ki67: International multicenter collaboration study

Free
B Acs, SC Leung, V Pelekanou, Y Bai, S Martinez-Morilla, M Toki, MC Chang, A Gholap, A Jadhav, JC Hugh, G Bigras, A Laurinavicius, R Augulis, R Levenson, A Todd, T Piper, S Virk, B van der Vegt, DF Hayes, M Dowsett, TO Nielsen, DL Rimm
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): P4-02-01.
https://doi.org/10.1158/1538-7445.SABCS18-P4-02-01
Published: 15 February 2019
View articletitled, Abstract P4-02-01: Analytical validation of an automated digital scoring protocol for Ki67: International multicenter collaboration study
Journal Articles

Abstract P4-15-01: Acquired ESR1 mutation and persistent expression of estrogen regulated genes in ER+ breast cancers on long-term neoadjuvant treatment with aromatase inhibitors

Free
MF Leal, BP Haynes, E Schuster, B Yeo, M Afentakis, A Dodson, R Buus, MC Cheang, L-A Martin, M Dowsett
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): P4-15-01.
https://doi.org/10.1158/1538-7445.SABCS18-P4-15-01
Published: 15 February 2019
View articletitled, Abstract P4-15-01: Acquired ESR1 mutation and persistent expression of estrogen regulated genes in ER+ breast cancers on long-term neoadjuvant treatment with aromatase inhibitors
Journal Articles

Abstract GS3-02: PALLET: A neoadjuvant study to compare the clinical and antiproliferative effects of letrozole with and without palbociclib

Free
M Dowsett, S Jacobs, S Johnston, J Bliss, D Wheatley, C Holcombe, R Stein, S McIntosh, P Barry, D Dolling, C Snowdon, S Perry, L Batten, A Dodson, V Martins, A Modi, C Cornman, S Puhalla, N Wolmark, T Julian, K Pogue-Geile, A Robidoux, L Provencher, JF Boileau, I Shalaby, M Thirlwell, K Fisher, C Huang Bartlett, M Koehler, K Osborne, M Rimawi
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): GS3-02.
https://doi.org/10.1158/1538-7445.SABCS18-GS3-02
Published: 15 February 2019
View articletitled, Abstract GS3-02: PALLET: A neoadjuvant study to compare the clinical and antiproliferative effects of letrozole with and without palbociclib
Journal Articles

Abstract P2-07-02: A newly derived combined clinical treatment score and immunohistochemical-4 prognostic tool

Free
A Dodson, I Sestak, J Bayani, M Dowsett, J Bartlett, J Cuzick
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): P2-07-02.
https://doi.org/10.1158/1538-7445.SABCS18-P2-07-02
Published: 15 February 2019
View articletitled, Abstract P2-07-02: A newly derived combined clinical treatment score and immunohistochemical-4 prognostic tool
Journal Articles

Abstract P2-08-04: Prediction of distant recurrence by EndoPredict in patients with estrogen receptor-positive, HER2-negative breast cancer who received adjuvant endocrine therapy plus chemotherapy (ET+C) or endocrine therapy alone (ET)

Free
I Sestak, M Martin, P Dubsky, F Rojo, J Cuzick, M Filipits, A Ruiz, R Buus, D Hlauschek, A Rodriguez-Lescure, M Dowsett, M Gnant
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): P2-08-04.
https://doi.org/10.1158/1538-7445.SABCS18-P2-08-04
Published: 15 February 2019
View articletitled, Abstract P2-08-04: Prediction of distant recurrence by EndoPredict in patients with estrogen receptor-positive, HER2-negative breast cancer who received adjuvant endocrine therapy plus chemotherapy (ET+C) or endocrine therapy alone (ET)
Journal Articles

Abstract P4-08-02: Importance of adverse events during endocrine treatment for the prediction of late distant recurrences

Free
I Sestak, M Dowsett, J Cuzick
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): P4-08-02.
https://doi.org/10.1158/1538-7445.SABCS18-P4-08-02
Published: 15 February 2019
View articletitled, Abstract P4-08-02: Importance of adverse events during endocrine treatment for the prediction of late distant recurrences
Journal Articles

Abstract P1-09-03: Global knockdown of cellular kinases identifies MPS1 as a novel modulator of endocrine and palbociclib resistance highlighting a new role for MPS1 inhibitors

Free
J Nikitorowicz-Buniak, S Pancholi, N Simigdala, R Ribas, S Linardopoulos, M Dowsett, SR Johnston, L-A Martin
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): P1-09-03.
https://doi.org/10.1158/1538-7445.SABCS17-P1-09-03
Published: 15 February 2018
View articletitled, Abstract P1-09-03: Global knockdown of cellular kinases identifies MPS1 as a novel modulator of endocrine and palbociclib resistance highlighting a new role for MPS1 inhibitors
Journal Articles

Abstract GS6-01: Integration of clinical variables for the prediction of late distant recurrence in patients with oestrogen receptor positive breast cancer treated with 5 years of endocrine therapy

Free
I Sestak, M Regan, A Dodson, G Viale, B Thürlimann, M Colleoni, J Cuzick, M Dowsett
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): GS6-01.
https://doi.org/10.1158/1538-7445.SABCS17-GS6-01
Published: 15 February 2018
View articletitled, Abstract GS6-01: Integration of clinical variables for the prediction of late distant recurrence in patients with oestrogen receptor positive breast cancer treated with 5 years of endocrine therapy
Journal Articles

Abstract GS1-03: Peri-operative aromatase inhibitor treatment in determining or predicting longterm outcome in early breast cancer – The POETIC* Trial (CRUK/07/015)

Free
JFR Robertson, M Dowsett, JM Bliss, JP Morden, M Wilcox, A Evans, C Holcombe, K Horgan, C Kirwan, E Mallon, M Sibbering, A Skene, R Vidya, M Cheang, J Banerji, L Kilburn, A Dodson, I Smith
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): GS1-03.
https://doi.org/10.1158/1538-7445.SABCS17-GS1-03
Published: 15 February 2018
View articletitled, Abstract GS1-03: Peri-operative aromatase inhibitor treatment in determining or predicting longterm outcome in early breast cancer – The POETIC* Trial (CRUK/07/015)
Journal Articles

Abstract P3-08-01: Prognostic performance of EndoPredict in invasive lobular carcinoma

Free
I Sestak, R Kronenwett, C Denkert, J Cuzick, M Dowsett
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): P3-08-01.
https://doi.org/10.1158/1538-7445.SABCS17-P3-08-01
Published: 15 February 2018
View articletitled, Abstract P3-08-01: Prognostic performance of EndoPredict in invasive lobular carcinoma
Journal Articles

Abstract P3-13-01: Withdrawn

Free
JFR Robertson, JP Morden, M Dowsett, I Smith, JM Bliss
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): P3-13-01.
https://doi.org/10.1158/1538-7445.SABCS17-P3-13-01
Published: 15 February 2018
View articletitled, Abstract P3-13-01: Withdrawn
Journal Articles

Abstract PD5-05: Genomic instability and poor antiproliferative response to aromatase inhibitor treatment: A POETIC study

Free
EF Schuster, P Gellert, CV Segal, E López-Knowles, R Buus, J Morden, J Robertson, J Bliss, I Smith, M Dowsett, POETIC Trial Management Group and Trialists P
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): PD5-05.
https://doi.org/10.1158/1538-7445.SABCS17-PD5-05
Published: 15 February 2018
View articletitled, Abstract PD5-05: Genomic instability and poor antiproliferative response to aromatase inhibitor treatment: A POETIC study
Journal Articles

Abstract P2-03-01: Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration

Free
TO Nielsen, SCY Leung, LA Zabaglo, I Arun, SS Badve, AL Bane, JMS Bartlet, S Borgquist, MC Chang, A Dodson, A Ehinger, S Fineberg, CM Focke, D Gao, AM Gown, C Gutierrez, JC Hugh, Z Kos, A-V Lænkholm, MG Mastropasqua, T Moriya, S Nofech-Mozes, CK Osborne, FM Penault-Llorca, T Piper, T Sakatani, R Salgado, J Starczynski, T Sugie, B van der Vegt, G Viale, DF Hayes, LM McShane, M Dowsett
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): P2-03-01.
https://doi.org/10.1158/1538-7445.SABCS17-P2-03-01
Published: 15 February 2018
View articletitled, Abstract P2-03-01: Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration
Journal Articles

Abstract P2-02-01: Withdrawn

Free
NC Turner, I Garcia-Murillas, N Chopra, M Beaney, RJ Cutts, C Swift, D Kriplani, J Morden, S Hrebien, I Comino-Mendez, M Afentakis, J Bliss, A Skene, D Wheatley, S Russell, A Evans, M Dowsett, IE Smith
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): P2-02-01.
https://doi.org/10.1158/1538-7445.SABCS17-P2-02-01
Published: 15 February 2018
View articletitled, Abstract P2-02-01: Withdrawn
Journal Articles

Abstract P3-08-16: ER, PR and HER2 biomarkers in UK and Irish clinical breast cancer testing: analysis of results from >168,000 patients

Free
A Dodson, S Parry, M Ibrahim, J Bartlett, M Dowsett, K Miller
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): P3-08-16.
https://doi.org/10.1158/1538-7445.SABCS17-P3-08-16
Published: 15 February 2018
View articletitled, Abstract P3-08-16: ER, PR and HER2 biomarkers in UK and Irish clinical breast cancer testing: analysis of results from >168,000 patients